Price movement over the last 24 hours
Enact Holdings Inc vs Canopy Growth Corp — how do they compare? Enact Holdings Inc trades at $44.96 (market cap $6.35B), while Canopy Growth Corp trades at $0.96 (market cap $404.40M). The key difference: Enact Holdings Inc is far larger — about 15.7× Canopy Growth Corp's market cap, and Enact Holdings Inc pays a 1.91% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| ACT | CGC | |
|---|---|---|
Market Cap | $6.35B | $404.40M |
Sector | Technology | Health |
52-Week High | $45.71 | $1.92 |
52-Week Low | $34.39 | $0.86 |
Enterprise Value | $6.55B | $343.85M |
Dividend Yield | 1.91% | — |
Signals from Pluang's Aura AI — not financial advice
ACT trades at $45.69, up 0.77% today, with a bullish technical signal and strong moving averages. The stock shows robust fundamentals with a net income margin of 54.49% and a P/E ratio of 9.89. Recent news includes a 14% dividend increase announced on May 5, 2026, and Q1 2026 earnings that met expectations. Analyst consensus is a $47.50 price target with a mix of buy and hold ratings.
Outlook remains positive due to high profitability and dividend growth, but risks include earnings volatility and market sensitivity. Upside is supported by institutional sentiment and consistent cash flow, though investors should monitor execution against future earnings estimates.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →